Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

Abstract

The conversion of SBA into NAB depends to some degree on the SBA titer, but other mechanisms may be involved. Once NAB have developed, the bioavailability of IFNbeta as measured by MxA is completely inhibited.